Explore the latest in viral hepatitis, including recent advances in diagnosis and antiviral treatment of hepatitis B and C.
This cross-sectional study identifies the shortcomings of current drug pricing indexes to estimate drug price inflation and considers a new approach.
This Viewpoint describes new recommendations from the CDC regarding universal screening of adults for hepatitis B virus infection.
This Viewpoint outlines the progress made toward eliminating hepatitis B and C but emphasizes the work that remains to prioritize diagnosis and treatment of populations disproportionately affected by viral hepatitis, including ensuring that there are systems in place to treat those infected and care for those at risk.
This cohort study explores the association of maternal preconception hepatitis B virus infection with congenital heart diseases in offspring.
This Viewpoint introduces a proposed 5-year program from the Biden-Harris administration that would use direct-acting antivirals to eliminate hepatitis C in the United States.
This Medical News article is an interview with Francis S. Collins, MD, PhD, former National Institutes of Health director, and JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, about a historic Biden-Harris administration proposal to cure and prevent all hepatitis C infections in the US.
This cross-sectional study evaluates treatment with prescription medications in jails and state prisons relative to noncorrectional settings in the US.
This cohort study examines treatment for chronic hepatitis B among a racially diverse group of individuals in North America.
This retrospective cohort study of 245 596 adults with CHC examines the association of hepatitis C virus elimination with the risk of liver and nonliver morbidity and overall mortality from 2010 to 2021.
This cohort study of patients within the Veterans Health Administration assesses the association between alcohol use disorder and receipt of direct-acting antiviral treatment for hepatitis C virus (HCV) infection.
This cohort study assesses the prevalence of meeting successive markers of quality care for individuals with rheumatoid arthritis and characteristics associated with meeting these markers.
This cohort study evaluates hepatitis C virus (HCV) treatment rates and patient characteristics associated with treatment in the era of direct-acting antivirals and during the COVID-19 pandemic.
This cohort study examines the risk of graft failure associated with donors with hepatitis C virus (HCV) infection before and after the introduction of direct-acting antiviral medications.
This narrative review investigates the current published case series and case-control studies of pediatric patients with acute hepatitis of unknown etiology.
Customize your JAMA Network experience by selecting one or more topics from the list below.